Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
4(31%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
1
8%
Ph phase_2
1
8%
Ph phase_1
5
38%
Ph early_phase_1
1
8%

Phase Distribution

6

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 1Safety & dosage
5(62.5%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

13

all time

Status Distribution
Active(6)
Completed(6)
Other(1)

Detailed Status

Completed6
Recruiting3
Not yet recruiting2
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 15 (62.5%)
Phase 21 (12.5%)
N/A1 (12.5%)

Trials by Status

active_not_recruiting18%
completed646%
unknown18%
recruiting323%
not_yet_recruiting215%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
PROCEDURE
Total Trials
13